Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IBS, Diarrhea Predominant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00230581
What this trial is testing

8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS

Who this might be right for
Irritable Bowel Syndrome
Dynogen Pharmaceuticals 88
Not applicableStudy completedNCT02431533
What this trial is testing

The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
Pharmabiotix Inc 50
Not applicableStudy completedNCT04898257
What this trial is testing

Effect of Lactibiane Tolerance® to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Patients

Who this might be right for
IBS - Irritable Bowel Syndrome
Larena SAS 30
Testing effectiveness (Phase 2)Study completedNCT00699166
What this trial is testing

Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome
Novartis 135
Not applicableStudy completedNCT02661425
What this trial is testing

Retrospective Study of IBS-D Patients Previously Receiving SBI

Who this might be right for
Diarrhoea Predominant Irritable Bowel Syndrome
Entera Health, Inc 165
Not applicableStudy completedNCT07520422
What this trial is testing

Bacillus Coagulans Based Product in IBS-Diarrhea

Who this might be right for
IBS-D (Diarrhea-predominant)
Bioagile Therapeutics Pvt. Ltd. 50
Testing effectiveness (Phase 2)Ended earlyNCT06153420
What this trial is testing

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
CinPhloro Pharma, LLC 421
Post-approval studies (Phase 4)Study completedNCT01225237
What this trial is testing

Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients

Who this might be right for
Irritable Bowel Syndrome
Astellas Pharma Inc 296
Not applicableEnded earlyNCT00219505
What this trial is testing

Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBS

Who this might be right for
Irritable Bowel Syndrome
Penn State University 36
Not applicableNot Yet RecruitingNCT07172139
What this trial is testing

Transcranial Magnetic Stimulation and Pharmacologic/Probiotic Interventions for Diarrhea-Predominant IBS

Who this might be right for
IBS (Irritable Bowel Syndrome)
Rui Li 140
Not applicableStudy completedNCT05754177
What this trial is testing

Safety and Efficacy of a Probiotic Supplement in IBS-D

Who this might be right for
Irritable Bowel Syndrome With DiarrheaIrritable Bowel Syndrome
The Archer-Daniels-Midland Company 46
Post-approval studies (Phase 4)Study completedNCT00370032
What this trial is testing

Study to Assess the Effect Of Alosetron On Mucosal Blood Flow

Who this might be right for
Irritable Colon
GlaxoSmithKline 49
Post-approval studies (Phase 4)Study completedNCT01316718
What this trial is testing

Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhoea
University of Nottingham 108
Not applicableStudy completedNCT06676514
What this trial is testing

Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D

Who this might be right for
IBS-D (Diarrhea-predominant)
Liaquat University of Medical & Health Sciences 405
Testing effectiveness (Phase 2)Study completedNCT01494233
What this trial is testing

A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Lexicon Pharmaceuticals 373
Large-scale testing (Phase 3)Looking for participantsNCT07168434
What this trial is testing

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome

Who this might be right for
IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)IBS, Mixed Symptoms
Biocodex 406
Not applicableStudy completedNCT05339243
What this trial is testing

Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
Vedic Lifesciences Pvt. Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT01844180
What this trial is testing

A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome (IBS)
Ono Pharma USA Inc 200
Not applicableUnknownNCT02565654
What this trial is testing

Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
First Affiliated Hospital, Sun Yat-Sen University 120
Not applicableEnded earlyNCT00179582
What this trial is testing

Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS

Who this might be right for
IBS
Beth Israel Deaconess Medical Center 180
Next Page